Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection

Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection
复制标题

DOI:
10.1097/01.qai.0000131932.21612.49
复制
发表时间:
2004-11-01
影响因子:
3.6
通讯作者:
Klein, RS
Klein, RS
中科院分区:
医学3区
文献类型:
--
作者:
Fishbein, DA;Lo, YT;Klein, RS

文献摘要

被引文献

相似文献

本研究的目的是确定转介吸毒者(DU)与慢性丙型肝炎的临床评估和护理的结果。228名可检测到丙型肝炎病毒RNA的患者接受了快速转诊,以进行丙型肝炎的评估和可能的治疗,这些患者来自当前和既往阿片类药物成瘾DU的前瞻性研究队列。四个结果进行了分析:接受转诊,到达临床评估,肝活检,并接受治疗。127名参与者(56%)接受转诊,其中54名(43%)接受评价。在这些参与者中,12例(22%)进行了肝活检,4例(7%)接受了治疗。多变量logistic回归分析显示,HIV感染的DU接受转诊的可能性显著降低(调整后的比值比[ORadj],0.51; 95%置信区间[CI],0.30-0.88),老年参与者更有可能保持预约(ORadj,1.06/y; 95% CI,1.00-1.12)。在艾滋病毒血清反应阳性的参与者中,有注射史的参与者更有可能接受转诊(ORadj,3.60; 95% CI,1.08-11.96),以及HIV载量较高的人群(ORadj,0.50/log(10); 95% CI,0.26-0.94)和西班牙裔(ORadj,0.26; 95% CI,0.07-0.89)不太可能遵守约定。尽管加快了丙型肝炎护理的转诊,但只有少数参与者接受了评估,接受治疗的人数更少。由于越来越有效的治疗,迫切需要更好的方法来改善HCV感染DU的评估和治疗,包括那些合并感染HIV的DU。
The objective of this study was to determine outcomes of referring drug users (DUs) with chronic hepatitis C for clinical evaluation and care. Two hundred twenty-eight persons with detectable hepatitis C virus RNA were given expedited referrals for evaluation and possible treatment of hepatitis C from a prospective study cohort of current and former opiate-addicted DUs. Four outcomes were analyzed: accepted referral, arrived for clinical evaluation, had liver biopsy, and received treatment. One hundred twenty-seven participants (56%) accepted referral, of whom 54 (43%) arrived for evaluation. Of these participants, 12 (22%) had liver biopsy, and 4 (7%) were treated. Multivariate logistic regression revealed that HIV-infected DUs were significantly less likely to accept referral (adjusted odds ratio [ORadj], 0.51; 95% confidence interval [CI], 0.30-0.88), and older participants were more likely to keep an appointment (ORadj, 1.06/y; 95% CI, 1.00-1.12). Of HIV-seropositive participants, those with a history of injection were more likely to accept referral (ORadj, 3.60; 95% CI, 1.08-11.96), and those with higher HIV load (ORadj, 0.50/log(10); 95% CI, 0.26-0.94) and Hispanic ethnicity (ORadj, 0.26; 95% CI, 0.07-0.89) were less likely to keep an appointment. Despite expedited referrals for hepatitis C care, only a few participants received an evaluation, and even far fewer were treated. Because increasingly effective treatment is available, better methods are urgently needed to improve evaluation and treatment of HCV-infected DUs, including those coinfected with HIV.